Case Reports in Pathology

Case Reports in Pathology / 2018 / Article

Case Report | Open Access

Volume 2018 |Article ID 7462032 | 6 pages |

Florid Proliferation of Hyalinized Vessels in a Spermatic Cord STAT6 Positive Solitary Fibrous Tumor and Its Potential Clinical Implications

Academic Editor: Stefan Pambuccian
Received07 Feb 2018
Accepted23 May 2018
Published28 Jun 2018


A solitary fibrous tumor (SFT) arising in the paratesticular region is a rare event. Typically most SFTs present as a lung mass and have a characteristic microscopic appearance. Although uncommon, SFTs may present at just about any anatomical site. Here we present a case of a SFT arising along the right spermatic cord, with histologic features mimicking a cellular angiofibroma. We describe the diagnostic immunohistochemical markers useful for arriving at its diagnosis. We also summarize our current understanding of the structural and molecular features that make up SFTs and discuss how these features may help us better understand the pathophysiology of pluripotent mesenchymal stem cell differentiation.

1. Introduction

SFTs typically present as a lung mass arising from the visceral pleura; however, since its description in 1931, extrapleural tumors have been identified at various other anatomical locations [1]. SFTs can present at any age, and while pleural SFTs most often occur during the and decades of life, extrapleural SFTs tend to manifest in adults aged 20 to 70 years old. SFTs have no sex predilection, except for the extrapleural fat-forming SFT variant, which is seen slightly more often in males than females. SFTs usually are benign and slow-growing; however, 10% of patients will have tumors that behave aggressively. To date, SFTs have not been linked to any etiologic agent [2, 3]. A solitary fibrous tumor presenting in the paratesticular region is unusual. To the best of our knowledge, at least 21 cases are reported in the literature, of which 9 were specifically noted to have arisen along the spermatic cord (Table 1).

ReferencesAgeGreatest dimension (cm)RegionLaterality

Fisher C, et al. [4]4610Spermatic CordNS
Gold JS, et al. [5]NSNSSpermatic CordNS
Xambre L, et al. [6]6710Spermatic CordR
Honeck P, et al. [7]644.3Spermatic CordLeft
Ilica AT, et al. [8]2014Spermatic CordRight
Arrabal-Polo MA, et al. [9]445Spermatic CordLeft
Topsakal K, et al. [10]215Spermatic CordLeft
Barazani Y, et al. [11]266.2Spermatic CordLeft
Hu S, et al. [12]313Spermatic CordLeft
Jones MA, et al. (2 cases) [13]NSNSScrotumNS
Shim JW, et al. [14]3811ScrotumLeft
Márquez Moreno AJ, et al. [15]679ScrotumLeft
Ch Tsili A, et al. [16]651.9ScrotumLeft
García Torrelles M, et al. [17]222.5ScrotumLeft
Varela R, et al. [18]6420ScrotumRight
Lee GE, et al. [19]615ScrotumLeft
Parikh BJ, et al. [20]428ScrotumLeft
Zhou Y, et al. [21]615.1ScrotumLeft
Zhao X, et al. [22]7711ScrotumRight
Gutierrez-Diaz CM, et al. [23]53NSParatesticularNS

NS: not specified.

Herein we report a case of a SFT arising along the right spermatic cord, with features mimicking a cellular angiofibroma. The diagnosis of SFT was ultimately confirmed by nuclear expression of STAT6 in the tumoral cells.

2. Case

A 48-year-old male presented in surgery clinic with a clinical history of benign prostatic hyperplasia and a 6-year history of an enlarging right inguinal hernia, with associated increase in discomfort. On physical examination, a cystic mass was palpated on the superior right testicle, and a firm, solid mass was found in the right groin. The testicular mass was fully mobile within the subcutaneous space and minimally tender and did not appear to be connected to the external ring. The patient had no other complaints, and the rest of his physical examination was unremarkable. A follow-up computed tomography (CT) scan revealed a partially visualized, heterogenous, and enhancing right inguinal mass, raising the concern for a peripheral nerve sheath tumor or sarcoma of the spermatic cord (Figure 1).

The mass was surgically excised from the spermatic cord. During surgery, it was noted that the mass was located inside the external cord, but outside of the internal spermatic fascia. It had eroded through the aponeurosis of the external oblique muscle. Nonetheless, the mass could easily be separated from the spermatic cord and was submitted to pathology for evaluation. Macroscopically, the mass weighed 67.5 grams and measured 7 x 5.5 x 2.5 centimeters. Its outer surface was smooth, pink/white in color and covered by a thin membrane. The cut surface of the mass was white and firm and had a whorled texture containing occasional small cysts (Figure 2(a)). The tumor border is well delineated. The margin is inked green (Figure 2(b)).

Microscopically, the tumor had a heterogeneous pattern-less architecture with alternating hypocellular and hypercellular areas, interstitial hyalinization, and intermixed with ropy collagen bands (Figure 3(a)). The most prominent feature of the tumor was found within the vascular compartment. Numerous small- to medium-sized vessels were present and showed a continuum of changes, ranging from thick-walled vessels showing proliferation of myocytes, to vessels revealing intimal thickening, to vessels with circumferential prominent mural hyalinization (Figure 3(b)). Some of the larger vessels displayed subendothelial mucoid degeneration resembling vascular changes observed during accelerated hypertension (Figure 3(c)). When the course of one of the vessels was followed, the vessel was found to have cellular myocytic proliferation in some segments followed by hyalinization in other segments. Occasional individual exuberant hemangiopericytoma-like vascular channels were also present (Figure 3(d)).

The neoplastic cells were ovoid to spindle-shaped with scanty pale cytoplasm and oval to fusiform nuclei (Figure 3(e)). Mitosis was scarce and at less than one per 10 high power fields, and the margins were free of tumor. Immunohistochemical results for the patient are listed in Table 2. The tumoral cells expressed CD34, BCL-2, and CD99. They were also focally positive for Estrogen Receptor (ER) and Progesterone Receptor (PR) and negative for Smooth Muscle Actin (SMA) and S100. A STAT6 stain was ordered and revealed nuclear positivity in the tumoral cells but negative staining in the vascular myocytes (Figure 3(f)). No follow-up data is available due to the recent removal of the tumor at the time of writing of this case report.

ImmunostainCellular AngiofibromaSFTPatient’s Tumor

CD34 [1, 2]+ (60%)+ (80-95 %)+
ER [24, 25]+ (35%)+ (focal)
PR [24, 25]+ (55%)+ (patchy)+ (focal)
SMA [1, 24]+ (21%)+ (20%)
S100 [1, 2]– (usually)
CD99 [26, 27]+ (2 of 4 cases reported)+ (70-94 %)+
bcl2 [1, 26]Not reported+ (30-96 %)+
STAT6 [3, 28]+ (>95%)+ (Figure 3(f))

3. Discussion

Initially SFTs were believed to be tumors of pericytic origin; however, over the years and through ultrastructural studies, it was discovered that SFTs are tumors with neoplastic cellular heterogeneity consisting of undifferentiated perivascular cells, fibroblasts, myofibroblasts, pericytes, smooth muscle cells, and endothelial cells, all possibly arising from adult mesenchymal stem cells [1, 29, 30]. The relative proportion of each component within the tumor may be different from one SFT to the next [30]. SFT’s anatomical presentation and characteristic architectural features usually help to distinguish it from other tumors. The tumor can vary greatly in appearance, depending on the relative proportion of tumoral cells to the surrounding fibrous stroma, with the classical hemangiopericytoma being at the cellular end of the spectrum, and the hyalinized form at the other end of the spectrum, representing the classical solitary fibrous tumor [1]. Characteristically, SFTs have a pattern-less architecture, with alternating hypercellular and hypocellular areas separated by bands of hyaline, and numerous thin-walled branching staghorn vessels. The neoplastic cells are typically ovoid to spindle-shaped, with limited pale cytoplasm, and scarce mitotic figures. SFTs may resemble benign neural or smooth muscle tumors. Our tumor is distinct from the typical presentation of SFTs, by its formation along the spermatic cord and morphological similarity to a cellular angiofibroma; moreover, the sequences of changes starting with myocyte proliferation, transmural myxoid changes, and then partial to complete circumferential hyalinosis were unique vascular features.

The presentation along the spermatic cord in our patient had led to a misdiagnosis of inguinal hernia for several years, thus delaying tumor removal. Therefore, even though spermatic cord SFT is a rare tumor, it should be considered in the differential diagnosis of spermatic cord masses, by the clinician. Another benign mesenchymal tumor in the urogenital region that can be confused with a spermatic cord SFT is cellular angiofibroma which is typically seen in the superficial soft tissue of the genital region, with the inguinal region being the most common site in men [26]. Histologically, our tumor had some important features of a cellular angiofibroma, notably presence of florid proliferation of minute-small- to medium-sized vessels with hyalinized walls.

The tumoral cells expressed CD34, ER, and PR, but not SMA or S100. This phenotype initially supported a diagnosis of cellular angiofibroma; however, additional staining of the spindle cells demonstrated CD99 and BCL-2 expression, raising the suspicion for SFT. Ultimately, the strong diffuse positive nuclear staining for STAT6 in the neoplastic cells established a diagnosis of spermatic cord SFT [31, 32]. If our case had been negative for STAT6, as is seen in a subset of SFT cases [3], then additional staining for desmin and FISH testing for RB1 and FOXO1 loci on chromosome 13q14 may be helpful [26]. Desmin is usually negative in SFTs [1] but may be positive in about 8% of cellular angiofibromas [24]. The deletion of the RB1 and FOXO1 loci would also support a diagnosis of cellular angiofibroma.

Of note, another important diagnostic consideration along the spermatic cord is the possibility of a dedifferentiated liposarcoma (DDLPS). Although rare, more cases have been reported of DDLPS along the spermatic cord than SFT [33]. However, there are several histologic clues that argue against a DDLPS in our case. It has also been shown that about 11% of DDLPS may show STAT6 expression secondary to amplification. In a study by Doyle et al., a total of 4 out of 35 cases (11%) examined showed STAT6 expression. Three showed moderate-to-strong multifocal staining and one with weak focal staining [34]. This is in contrast to our case, which showed strong diffuse positive nuclear staining. SFTs typically show diffuse nuclear staining (> 90% of cases), whereas cytoplasmic, not nuclear, staining is typically seen in > 95% of non-SFT cases expressing STAT6 [35]. Another typical feature seen in DDLPS, and not seen in our case, includes an architectural transition between the dedifferentiated component (increased mitosis and atypia) and the well-differentiated component of liposarcoma. Additionally, DDLPS tend to be of larger size, multinodular, and necrotic in the dedifferentiated component [36]. Nonetheless, if clinically suspected, it would be necessary to exclude DDLPS with MDM2 and CDK4 immunohistochemistry.

The vessels themselves did not share the same immunohistochemical pattern as the tumoral cells but expressed the staining patterns typically seen in normal vessels including CD34 positivity and STAT6 negativity. It may well be possible that the vascular myocytic proliferation seen in our case represents an angiogenic response to mitogens produced by the tumor, such as platelet-derived growth factor (PDGF) [30]. In 2013, Robinson and collogues demonstrated that PDGF-D, a potent transforming and angiogenic growth factor [37], showed significantly higher levels in SFTs compared to other tumor types. They postulated that the fusion of NAB2 gene with STAT6 gene, converted NAB2 from an early growth response 1 (EGR-1) repressor to an EGR-1 activator and that this genetic fusion is the driving factor in the development of SFTs [38]. The authors of this article believe that developing animal models of SFT through genetic engineering and induction of NAB2-STAT 6 fusion gene can be the next step in the research and development of treatment options for diseases linked to fibroblastic proliferation such as systemic sclerosis, interstitial lung disease, pulmonary hypertension, and even arteriosclerosis and malignant hypertension.

SFT is a great example of how next-generation sequencing has opened the doors of our understanding regarding tumor initiation and development over time. As we continue to learn more about this uncommon but interesting tumor, we may find that this tumor yet holds secrets to the pathophysiology of pluripotent mesenchymal stem cell differentiation.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this article.


  1. J. R. Goldblum, A. L. Folpe, and S. W. Weiss, “Soft Tissue Tumors of Intermediate Malignancy of Uncertain Type,” in Enzinger and Weiss's Soft Tissue Tumors, pp. 969–1027, Saunders, Philadelphia, Pa, USA, 6th edition, 2013. View at: Publisher Site | Google Scholar
  2. C. D. M. Fletcher, J. A. Bridge, and J. C. Lee, “Extrapleural solitary fibrous tumour,” in WHO Classification of Tumours of Soft tissue and Bone, C. D. M. Fletcher, Ed., pp. 80–82, IARC Press, Lyon, France, 4th edition, 2013. View at: Google Scholar
  3. C. D. M. Fletcher and A. Gibbs, “Solitary fibrous tumour,” in WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, W. D. Travis, Ed., pp. 178-179, IARC Press, Lyon, France, 4th edition, 2015. View at: Google Scholar
  4. C. FISHER and M. BISCEGLIA, “Solitary fibrous tumour of the spermatic cord,” British Journal of Urology, vol. 74, no. 6, pp. 798-799, 1994. View at: Publisher Site | Google Scholar
  5. J. S. Gold, C. R. Antonescu, C. Hajdu et al., “Clinicopathologic correlates of solitary fibrous tumors,” Cancer, vol. 94, no. 4, pp. 1057–1068, 2002. View at: Publisher Site | Google Scholar
  6. L. Xambre, R. Lages, M. Cerqueira et al., “Solitary fibrous tumour. Two additional case reports with urological implications,” Actas Urológicas Españolas, vol. 27, no. 10, pp. 832–838, 2003. View at: Publisher Site | Google Scholar
  7. P. Honeck, P. Ströbel, M. S. Michel et al., “Solitary fibrous tumour of the testes (SFT),” Aktuelle Urologie, vol. 39, no. 4, pp. 305–308, 2008. View at: Publisher Site | Google Scholar
  8. A. T. Ilica, F. Ors, M. Bag, I. Guvenc, C. Duran, and H. Buyukbayram, “An uncommon cause of inguinoscrotal swelling: Solitary fibrous tumor of the spermatic cord,” European Journal of Radiology Extra, vol. 67, no. 1, pp. 25–28, 2008. View at: Publisher Site | Google Scholar
  9. M. A. Arrabal-Polo, M. Pareja-Vilchez, M. Arrabal-Martin, and A. Zuluaga-Gomez, “Solitary fibrous tumor of the spermatic cord,” Saudi Medical Journal, vol. 30, no. 4, pp. 569-570, 2009. View at: Google Scholar
  10. K. Topsakal, H. Ak, and N. Yumurtas, “Solitary Fibrous Tumor of the Spermatic Cord: Case Report,” Turkiye Klinikleri Journal Urology, vol. 2, no. 1, pp. 33–36, 2011. View at: Google Scholar
  11. Y. Barazani and B. Tareen, “Rare case of paratesticular solitary fibrous tumour (lipomatous hemangiopericytoma),” Canadian Urological Association Journal, vol. 6, no. 3, pp. E131–E133, 2012. View at: Google Scholar
  12. S. Hu, L. Yi, L. Yang, and Y. Wang, “Solitary fibrous tumor of the spermatic cord: A case report and literature review,” Experimental and Therapeutic Medicine, vol. 9, no. 1, pp. 55–58, 2015. View at: Publisher Site | Google Scholar
  13. M. A. Jones, R. H. Young, and R. E. Scully, “Benign fibromatous tumors of the testis and paratesticular region: A report of 9 cases with a proposed classification of fibromatous tumors and tumor-like lesions,” The American Journal of Surgical Pathology, vol. 21, no. 3, pp. 296–305, 1997. View at: Publisher Site | Google Scholar
  14. J. W. Shim and Y. Ro, “Solitary Fibrous Tumor of the Scrotum: A case report,” The Korean Journal of Pathology, vol. 33, no. 4, pp. 295–298, 1999. View at: Google Scholar
  15. A. J. Márquez Moreno, L. Vicioso Recio, A. Castro Léon, J. L. Casals Sánchez, J. Alcázar Ramírez, and A. Matilla Vicente, “Paratesticular solitary fibrous tumor,” Archivos Españoles de Urología, vol. 54, no. 7, Article ID 716718, 2001. View at: Google Scholar
  16. A. C. Tsili, C. Tsampoulas, X. Giannakopoulos et al., “Solitary fibrous tumour of the epididymis: MRI features,” British Journal of Radiology, vol. 78, no. 930, pp. 565–568, 2005. View at: Publisher Site | Google Scholar
  17. M. García Torrelles, J. R. Beltrán Armada, I. Santolaya García, V. Carrascosa Lloret, M. Tarín Planes, and C. San Juan De Laorden, “Solitary fibrous tumor of the tunica vaginalis testis,” Archivos Españoles de Urología, vol. 59, no. 2, pp. 186–189, 2006. View at: Google Scholar
  18. R. Varela, H. A. García, and V. Cortés, “Testicular hemangiopericytoma, solitary fibrous tumor: A very rare case,” Archivos Españoles de Urología, vol. 63, no. 9, pp. 816–819, 2010. View at: Google Scholar
  19. G. E. Lee, S. E. Rha, J. Y. Byun, K. Lee, and S. W. Kim, “Paratesticular solitary fibrous tumor: A rare cause of a hypervascular extratesticular mass,” Journal of Ultrasound in Medicine, vol. 30, no. 2, pp. 279–281, 2011. View at: Publisher Site | Google Scholar
  20. B. J. Parikh, S. B. Parikh, S. I. Panjvani, A. A. Shah, and D. S. Joshi, “Paratesticular Solitary Fibrous Tumour: A Case Report,” Gujarat Medical Journal, vol. 67, no. 2, pp. 126–128, 2012. View at: Google Scholar
  21. Y. Zhou, G. Gong, Y. Tang, J. Tang, Y. Gan, and Y. Dai, “Paratesticular solitary fibrous tumor: A case report and review of literature,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 3, pp. 3358–3361, 2015. View at: Google Scholar
  22. X. Zhao, M. Zeng, Q. Yang, C. Jing, and Y. Zhang, “Scrotum solitary fibrous tumor,” Medicine, vol. 96, no. 48, p. e8854, 2017. View at: Publisher Site | Google Scholar
  23. C. M. Gutierrez-Diaz, A. Hernandez-Solis, H. Cruz-Ortiz, Y. Gonzalez-Atencio, and R. Cicero-Sabido, “Solitary fibrous tumor. Clinic and pathological study of 16 cases,” Cirugía y Cirujanos, vol. 79, pp. 417–423, 2011. View at: Google Scholar
  24. Y. Iwasa and C. D. M. Fletcher, “Cellular angiofibroma: clinicopathologic and immunohistochemical analysis of 51 cases,” The American Journal of Surgical Pathology, vol. 28, no. 11, pp. 1426–1435, 2004. View at: Publisher Site | Google Scholar
  25. M. Bongiovanni, L. Viberti, C. Pecchioni et al., “Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells,” The Journal of Pathology, vol. 198, no. 2, pp. 252–257, 2002. View at: Publisher Site | Google Scholar
  26. U. Flucke, J. H. J. van Krieken, and T. Mentzel, “Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma,” Modern Pathology, vol. 24, no. 1, pp. 82–89, 2011. View at: Publisher Site | Google Scholar
  27. Y. Han, Q. Zhang, X. Yu et al., “Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors/hemangiopericytomas,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 10, pp. 13166–13175, 2015. View at: Google Scholar
  28. E. G. Demicco, P. W. Harms, R. M. Patel et al., “Extensive survey of STAT6 expression in a large series of mesenchymal tumors,” American Journal of Clinical Pathology, vol. 143, no. 5, pp. 672–682, 2015. View at: Publisher Site | Google Scholar
  29. Y. Rodríguez-Gil, M. A. González, C. B. Carcavilla, and J. S. Santamaría, “Lines of cell differentiation in solitary fibrous tumor: an ultrastructural and immunohistochemical study of 10 cases,” Ultrastructural Pathology, vol. 33, no. 6, pp. 274–285, 2009. View at: Publisher Site | Google Scholar
  30. F. Ide, K. Obara, K. Mishima, I. Saito, and K. Kusama, “Ultrastructural spectrum of solitary fibrous tumor: A unique perivascular tumor with alternative lines of differentiation,” Virchows Archiv, vol. 446, no. 6, pp. 646–652, 2005. View at: Publisher Site | Google Scholar
  31. S.-C. Huang, C.-F. Li, Y.-C. Kao et al., “The clinicopathological significance of NAB2-STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors,” Cancer Medicine, vol. 5, no. 2, pp. 159–168, 2016. View at: Publisher Site | Google Scholar
  32. L. A. Doyle, M. Vivero, C. D. M. Fletcher, F. Mertens, and J. L. Hornick, “Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics,” Modern Pathology, vol. 27, no. 3, pp. 390–395, 2014. View at: Publisher Site | Google Scholar
  33. O. N. Kryvenko, A. E. Rosenberg, M. Jorda, and J. I. Epstein, “Dedifferentiated liposarcoma of the spermatic cord: A series of 42 cases,” The American Journal of Surgical Pathology, vol. 39, no. 9, pp. 1219–1225, 2015. View at: Publisher Site | Google Scholar
  34. L. A. Doyle, D. Tao, and A. Mariño-Enríquez, “STAT6 is amplified in a subset of dedifferentiated liposarcoma,” Modern Pathology, vol. 27, no. 9, pp. 1231–1237, 2014. View at: Publisher Site | Google Scholar
  35. A. Yoshida, K. Tsuta, M. Ohno et al., “STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors,” The American Journal of Surgical Pathology, vol. 38, no. 4, pp. 552–559, 2014. View at: Publisher Site | Google Scholar
  36. A. P. Dei Tos, A. Marino-Enriquez, F. Pedeutour, and S. Rossi, “Dedifferentiated liposarcoma,” in WHO Classification of Tumours of Soft tissue and Bone, C. D. M. Fletcher, Ed., pp. 37-38, IARC Press, Lyon, France, 4th edition, 2013. View at: Google Scholar
  37. H. Li, L. Fredriksson, X. Li, and U. Eriksson, “PDGF-D is a potent transforming and angiogenic growth factor,” Oncogene, vol. 22, no. 10, pp. 1501–1510, 2003. View at: Publisher Site | Google Scholar
  38. D. R. Robinson, Y.-M. Wu, S. Kalyana-Sundaram et al., “Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing,” Nature Genetics, vol. 45, no. 2, pp. 180–185, 2013. View at: Publisher Site | Google Scholar

Copyright © 2018 Christopher P. Marquez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

534 Views | 265 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.